Corrigendum to ‘An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins – From superoxide dismutation to H(2)O(2)-driven pathways’ [Redox Biology 5C (2015) 43–65]

Documenti analoghi

• An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins – From superoxide dismutation to H(2)O(2)-driven pathways
  di: Batinic-Haberle, Ines, et al.
  Pubblicazione: (2015)
• Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury
  di: Batinic-Haberle, Ines, et al.
  Pubblicazione: (2018)
• Design, Mechanism of Action, Bioavailability and Therapeutic Effects of Mn Porphyrin-Based Redox Modulators
  di: Tovmasyan, Artak, et al.
  Pubblicazione: (2013)
• Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP(5+), and its alkoxyalkyl analogues
  di: Rajic, Zrinka, et al.
  Pubblicazione: (2017)
• Ascorbate-dependent and ascorbate-independent Mn porphyrin cytotoxicity: anticancer activity of Mn porphyrin-based SOD mimics through ascorbate-dependent and -independent routes
  di: Hasan, Bader, et al.
  Pubblicazione: (2021)